| |
|
|
|
|
|
|
|||
|
Blood, 1 July 2005, Vol. 106, No. 1, pp. 7.
The sticky matter of young versus old plateletsNOVARTIS ONCOLOGY
Two populations of thrombocytes have been distinguished in zebrafish that appear to play different roles in arterial thrombus formation.
As instigators of clot formation, young thrombocytes appear to have several things going for them: they have a higher receptor density and also are functionally more active as demonstrated by P-selectin levels, annexin V binding, and the release of calcium after adenosine diphosphate (ADP) activation. These cells cluster with themselves initially. Though more slowly activated, older thrombocytes also seem to first cluster with themselves. Subsequently, mosaic aggregates of young and old thrombocytes appear in the clot. The work by Thattliyath et al raises a number of interesting questions. What are the specific molecular and cellular changes that take place as platelets mature? What role do each of the platelet populations play in normal hemostasis? Although the authors have identified a decline in the number of surface receptors as one indication of platelet aging, there are undoubtedly other changes that take place as well. In addition, the authors suggest that older platelets may play a more structural role; however, this remains speculative. The system that Thattliyath et al have developed should facilitate further investigation into the details of platelet function through genetic manipulation and analysis of the resultant cell biology. This work will eventually lead to a better understanding of the role of different platelet populations. If the findings in zebrafish are found to be conserved in mammalian systems, these findings could have significant clinical relevance for the field of hemostasis and thrombosis.
It has been recognized for some time both experimentally and clinically that young platelets can have advantageous hemostatic properties. This has been illustrated experimentally in a rabbit model, and observationally in patients with immune thrombocytopenic purpura.1 However, whether such properties result solely from the larger size of the platelets or whether they are due to different inherent functional properties is not fully known. A better understanding of whether size, functionality, or a combination of the two is relevant for optimal hemostasis could eventually facilitate the development of more optimal techniques for platelet transfusion. In addition, understanding the role that young platelets play in clot formation could open the way for the development of novel antithrombotic agents aimed specifically at reducing the activity of this population of cells. References
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||
| Copyright © 2005 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||||